LINC02382

Across TCGA pan-cancer cohorts, LINC02382 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC02382 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher LINC02382 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02382 expression acts as an unfavorable survival marker, although some lineages such as BRCA and CESC show a favorable association.

ESCA, LIHC, and KIRP are the cancer types where LINC02382 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.235	0.806	.003	81	view →
LIHC	OS	Tertile	All	0.491	0.783	<.001	63	view →
KIRP	OS	Tertile	All	0.313	0.731	.004	60	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	45	view →
COAD	DFS	Tertile	IV	0.235	0.537	.001	36	view →
STAD	OS	Tertile	All	0.566	0.765	.019	27	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	24	view →
BRCA	OS	Tertile	II,III,IV	1.000	0.907	.032	21	view →
CESC	DFS	Tertile	II,III,IV	1.000	0.674	.036	12	view →
LUAD	OS	Tertile	II,III,IV	0.434	0.688	.025	12	view →
LUSC	DFS	Median	II,III,IV	0.767	0.675	.024	10	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC02382–ESCA (DFS)

Open the ESCA breakdown →